Advertisement
Canada markets open in 4 hours 2 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7312
    +0.0014 (+0.19%)
     
  • CRUDE OIL

    82.87
    +0.06 (+0.07%)
     
  • Bitcoin CAD

    87,612.11
    -3,318.06 (-3.65%)
     
  • CMC Crypto 200

    1,364.84
    -17.74 (-1.28%)
     
  • GOLD FUTURES

    2,338.60
    +0.20 (+0.01%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,510.50
    -154.00 (-0.87%)
     
  • VOLATILITY

    16.20
    +0.23 (+1.44%)
     
  • FTSE

    8,090.79
    +50.41 (+0.63%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

Why Inovio Stock Slid Today

Why Inovio Stock Slid Today

Shares of Inovio Pharmaceuticals (NASDAQ: INO) were sliding 5.2% lower as of 3:45 p.m. EST on Friday. The company announced earlier in the day that positive results from a phase 2 study evaluating INO-5401 and INO-9012 in combination with cancer immunotherapy Libtayo will be presented at the Society for Neuro-Oncology (SNO) 2020 Annual Meeting. In addition, investors appear to be much more heavily focused on Inovio's COVID-19 program than anything else right now.